PharmaCyte Biotech Drug Delivery Platform Limited only by Imagination
July 09 2015 - 10:00AM
InvestorsHub NewsWire
New York, July 10, 2015 - PharmaCyte Biotech, Inc. (OTCQB: PMBC)
“Cell-in-a-Box” platform exhibits significant potential. Any cell
type could potentially be implanted in the body without need for
administration of any drugs that decrease the body’s immune
response. This is important for potential therapies and will
dramatically increase versatility and value of this technology into
the future. The PMCB platform is a cellulose based "bead"
containing live cells. The porous nature of the beads allowed
nutrients to enter and support the health of the encapsulated
cells. In addition, beads are porous enough to permit activated
drugs or other biological substances to leave and provide benefit
to their surrounding environment.
This unique and patented technology will be used as a platform upon
which treatments for several types of cancer, including advanced,
inoperable pancreatic cancer, diabetes and delivery of cannabis
based treatments are being built.
For a brief report with analyst comments and recommendation on PMCB
please follow the link. There is no cost obligation required to
view report.
http://bit.ly/-PMCB_AnalystReport
Copy and paste to browser may be required.
About Small Cap Profit
We make the connection between sophisticated investors and high
quality small cap companies. An issuer of reports written research
analysts who provide an opinion of the profiled company. They
include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. For
more information and services provided beyond this release please
use contact information provided below.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis
by a 3rd party research analyst. However, we are only human and may
make mistakes. If you notice any errors or omissions, please notify
us below. A full disclaimer can be found by viewing the analyst
report.
Source: Small Cap Profit
Contact: editor@smallcapprofit.com